
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.060 | 6.160 | 0.100 |
Shares | 40.940 | 40.940 | 0.000 |
Bonds | 52.980 | 52.980 | 0.000 |
Convertible | 0.020 | 0.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.334 | 15.303 |
Price to Book | 3.469 | 2.132 |
Price to Sales | 1.222 | 1.588 |
Price to Cash Flow | 11.545 | 8.767 |
Dividend Yield | 3.189 | 2.579 |
5 Years Earnings Growth | 5.519 | 12.233 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 46.130 | 10.973 |
Consumer Defensive | 18.830 | 6.734 |
Industrials | 13.070 | 12.081 |
Technology | 8.740 | 18.049 |
Real Estate | 4.970 | 2.749 |
Consumer Cyclical | 4.460 | 12.925 |
Energy | 3.810 | 5.543 |
Number of long holdings: 44
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares 20+ Year Treasury Bond | US4642874329 | 8.44 | 85.01 | -0.70% | |
Novo Nordisk B | DK0062498333 | 8.34 | 433.1 | -2.28% | |
PepsiCo | US7134481081 | 3.90 | 133.81 | -1.30% | |
CVS Health Corp | US1266501006 | 3.80 | 63.94 | -0.65% | |
SAP | DE0007164600 | 3.58 | 259.800 | +0.68% | |
Siemens AG | DE0007236101 | 3.56 | 218.30 | -0.91% | |
Ceska Sporitelna AS 5.737% | XS2676413235 | 3.53 | - | - | |
Pandora A/S 4.5% | XS2596599147 | 3.52 | - | - | |
Electrolux AB 4.125% | XS2540585564 | 3.43 | - | - | |
CEZ AS 2.375% | XS2461786829 | 3.34 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Welzia Ahorro 5 FI | 60.21M | 0.85 | 4.16 | 1.26 | ||
Welzia USA Equity FI | 24.15M | 2.11 | 8.92 | 4.83 | ||
Welzia Crecimiento 15 FI | 20.24M | 1.69 | 8.37 | 4.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review